Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Dutasteride). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Dutamax is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
The recommended dose is one Dutasteride 0.5 mg capsule, taken by mouth once a day. Capsules should be swallowed whole rather than opened or chewed, and Dutasteride can be taken with or without food. No dose adjustment is needed for patients with kidney impairment or for older adults. Because no data are available for patients with liver impairment, no dosing recommendation can be given for this group. Pediatric use: Dutasteride is not approved for use in children, as its safety and effectiveness in the pediatric population have not been established. Geriatric use: Studies found no overall difference in safety or effectiveness between elderly and younger adult patients.
Side Effects
Sexual side effects can occur, such as reduced sexual interest or ability and a decrease in the amount of semen/sperm released during sex, as well as impotence (trouble getting or keeping an erection). Other effects include testicle pain or swelling, increased breast size, and breast tenderness.
Cautions & Contraindications
Warnings & Precautions
General: Lower urinary tract symptoms of BPH can be indicative of other urological diseases, including prostate cancer. Patients should be assessed to rule out other urological diseases prior to treatment with Urodart. Patients with a large residual urinary volume and/or severely diminished urinary flow may not be good candidates for 5 a-reductase inhibitor therapy and should be carefully monitored for obstructive uropathy. Blood Donation: Men being treated with Urodart should not donate blood until at least 6 months have passed following their last dose. The purpose of this deferred period is to prevent administration of Urodart to a pregnant female transfusion recipient.Use in hepatic impairment: The effect of hepatic impairment on Urodart pharmacokinetics has not been studied. Because Urodart is extensively metabolized and has a half-life of approximately 5 weeks at steady state, caution should be used in the administration of Urodart to patients with liver disease.Effects on prostate-specific antigen and prostate cancer detection: Digital rectal examinations, as well as other evaluations for prostate cancer, should be performed on patients with BPH prior to initiating therapy with Urodart and periodically thereafter. Urodart reduces total serum PSA concentration by approximately 40% following 3 months of treatment and approximately 50% following 6, 12, and 24 months of treatment. This decrease is predictable over the entire range of PSA values, although it may vary in individual patients.
Contraindications
Dutasteride should not be used by women, children, or anyone known to be hypersensitive to Dutasteride or other 5 alpha-reductase inhibitors. Warning: risk to a male fetus from exposure in women. Dutasteride can be absorbed through the skin, so women who are pregnant or may become pregnant should not handle Dutasteride capsules, as absorption of the drug could pose a potential risk to a male fetus. If skin contact occurs with a leaking capsule, the area should be washed right away with soap and water.